Ramesh Kumar
Director/Board Member at OCUGEN, INC.
Net worth: - $ as of 2024-04-29
Ramesh Kumar active positions
| Companies | Position | Start | End |
|---|---|---|---|
| OCUGEN, INC. | Independent Dir/Board Member | 2019-09-26 | - |
| Director/Board Member | 2019-09-26 | - | |
| Comptroller/Controller/Auditor | - | 2023-09-14 | |
| Ocugen OpCo, Inc. | Director/Board Member | 2019-05-31 | - |
Career history of Ramesh Kumar
Former positions of Ramesh Kumar
| Companies | Position | Start | End |
|---|---|---|---|
| TRAWS PHARMA, INC. | Director/Board Member | 2011-04-28 | 2019-01-14 |
| Chief Executive Officer | 1998-12-21 | 2019-01-14 | |
| Founder | 1998-12-21 | 2019-01-14 | |
| President | 1998-12-21 | 2018-06-20 | |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | - | - |
Nextran
 Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The private company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Director/Board Member | - | - |
| Kimeragen, Inc. | Corporate Officer/Principal | - | - |
| Princeton University | Corporate Officer/Principal | - | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Training of Ramesh Kumar
| University of Illinois | Doctorate Degree |
| Panjab University Chandigarh | Graduate Degree |
Statistics
International
| United States | 10 |
| India | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| OCUGEN, INC. | Health Technology |
| Private companies | 4 |
|---|---|
| Kimeragen, Inc. | Commercial Services |
Nextran
Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The private company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| Ocugen OpCo, Inc. |
- Stock Market
- Insiders
- Ramesh Kumar
- Experience